Drug Database
Back to search

Poland· PL-100482488

Chordyna

A tizanidine product containing tizanidinum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 14 of our 19 countries.

ATC M03BX02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedChordynaATCM03BX02REGISTER NO.PL-100482488PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tizanidinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tizanidine is registered in 14 of 19 countries.

Countries holding a registration under ATC M03BX02 (tizanidine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search tizanidine products by name

Tizanidine · ATC M03BX02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tizanidine costs, country by country.

Normalised to the WHO defined daily dose (12 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tizanidine · price per daily dose (12 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.38
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Tizanidinum
Manufacturer
Bausch Health Ireland Ltd.
Country
Poland (PL)
ATC code
M03BX02
ATC class
Tizanidine
Defined daily dose
12 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    5397313003848
  • gtin
    5397313003862
  • gtin
    05397313003848
  • gtin
    05397313003862

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

384 interactions on record for tizanidine.

Graded by severity as the source publishes them — 78 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tizanidine against other medicinesHow interaction checks work

Tizanidine · interactions on record

384 records

  • 78 severe
  • 177 moderate
  • 2 minor
  • 87 info

Most severe, free to view

  • CimetidineA02BA01severe
  • FamotidineA02BA03severe
  • PapaverineA03AD01severe
  • CisaprideA03FA02severe

40 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tizanidine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tizanidine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Sirdalud, Sirdalud Mr
  • Belgium · Sirdalud
  • Bulgaria · Tizanidine Teva, Тизанидин Tева
  • Czechia · Sirdalud
  • Germany · Sirdalud, Tizanidin Ascend
  • Denmark · Sirdalud Retard, Tizanidin Teva
  • Estonia · Sirdalud
  • Spain · Sirdalud
  • Finland · Sirdalud, Sirdalud Retard
  • United Kingdom (Northern Ireland) · Tizagelan, Tizanidine
  • Greece · Sirdalud
  • Croatia · Tizanidin Altamedics
  • Hungary · Sirdalud, Sirdalud Mr
  • Ireland · Tizanidine Teva
  • Italy · Navizan, Sirdalud
  • Lithuania · Sirdalud
  • Luxembourg · Sirdalud
  • Latvia · Sirdalud
  • Netherlands · Chordyna, Sirdalud
  • Portugal · Sirdalud, Tizanidina Teva
  • Slovenia · Sirdalud
  • Slovakia · Sirdalud

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5d2f2c8d-fa44-4946-9067-33b41028bb86
GET /v1/drugs/5d2f2c8d-fa44-4946-9067-33b41028bb86?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "4 mg",
  "packaging": "05397313003848 ¦ Rp ¦ 167282\n10 tabl.\n05397313003862 ¦ Rp ¦ 167283\n30 tabl.",
  "substance": "Tizanidini hydrochloridum 4.57 mg",
  "common_name": "Tizanidinum",
  "pl_product_id": "100482488",
  "pozwolenie_nr": "29768",
  "auth_procedure": "DCP",
  "authorisation_validity": "2031-06-11"
}
API referenceMCP serverPlans

See everything about tizanidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console